Concepedia

H Lenk

HL

Statistics

Publications

3

Citations

131

H-Index

3

Active since

1988

Affiliations

Asahi Chemical & Industry (Japan)(Current)

H Lenk is an author at Asahi Chemical & Industry (Japan) specializing in radiation oncology, cancer therapeutics, and medicine.

Top concepts

Publications per year

1988–1992

3

Publications

3

Phase II clinical trial of high-dose recombinant human tumor necrosis factor

H Lenk, S Tanneberger, U. M�ller et al. · Cancer Chemotherapy and Pharmacology · 1989 · 62 citations

, , +7

Mitoxantrone: mechanism of action, antitumor activity, pharmacokinetics, efficacy in the treatment of solid tumors and lymphomas, and toxicity.

H Lenk, Ulrich Müller, S Tanneberger · PubMed · 1988 · 47 citations

, , +13

A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.

E.D. Kreuser, R. U. Hilgenfeld, Michael A. Matthias et al. · PubMed · 1992 · 22 citations

1–3 of 3